Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterization of changes in extracellular matrix and cellular phenotypes in early calcific aortic valve disease
EF 2011-12
Résumé
Diseases of heart valves are a significant health problem in Canada. They are among the most common causes of heart disease and are associated with a high risk of morbidity. Specifically, the aortic valve is the most commonly affected. In aortic valve disease, structural and cellular components of the tissue are altered and prevent the valve from opening and closing normally. The resulting impaired valve function can lead to several serious consequences involving the heart. Currently, there is no effective medical therapy for aortic valve disease except replacement of the valve, when the disease has already reached the advanced stages.
The overall goal of this research project is to gain a better understanding of the early compositional changes in aortic valve disease. One of the earliest changes observed involve proteoglycan-rich lesions. Proteoglycans are structural molecules that are normally at low levels in the valve tissue. In vascular disease, they are known to aid in disease progression by binding lipids and inflammatory cells; thus, it is thought that they may play a similar role in valve disease.
The objectives of this study are to identify changes in specific proteoglycans and to identify differences in gene expression between lesion and non-lesion areas in early valve disease. These will be achieved using a pig model of aortic valve disease. Tissue sections of aortic valves will be stained to identify changes in quantity and distribution of specific proteoglycans. As well, cells in lesion and non-lesion areas will be isolated from these tissue sections so that differences in gene expression can analyzed between the two groups.
This study will further our basic knowledge of how aortic valve disease progresses in the early stages. This fundamental understanding may uncover new targets for earlier detection and therapeutic intervention, thereby reducing the impact of disease and improving health quality of life for millions of Canadians.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
255005
Name
Kwong Andrea V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Characterization of changes in extracellular matrix and cellular phenotypes in early calcific aortic valve disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Calcific Aortic Valve Disease; Immunohistochemistry; Laser Capture Microdissection; Microarray; Porcine Model; Proteoglycans/Glycosoaminoglycans; Valvular Interstitial Cells
Abstract
Diseases of heart valves are a significant health problem in Canada. They are among the most common causes of heart disease and are associated with a high risk of morbidity. Specifically, the aortic valve is the most commonly affected. In aortic valve disease, structural and cellular components of the tissue are altered and prevent the valve from opening and closing normally. The resulting impaired valve function can lead to several serious consequences involving the heart. Currently, there is no effective medical therapy for aortic valve disease except replacement of the valve, when the disease has already reached the advanced stages.
The overall goal of this research project is to gain a better understanding of the early compositional changes in aortic valve disease. One of the earliest changes observed involve proteoglycan-rich lesions. Proteoglycans are structural molecules that are normally at low levels in the valve tissue. In vascular disease, they are known to aid in disease progression by binding lipids and inflammatory cells; thus, it is thought that they may play a similar role in valve disease.
The objectives of this study are to identify changes in specific proteoglycans and to identify differences in gene expression between lesion and non-lesion areas in early valve disease. These will be achieved using a pig model of aortic valve disease. Tissue sections of aortic valves will be stained to identify changes in quantity and distribution of specific proteoglycans. As well, cells in lesion and non-lesion areas will be isolated from these tissue sections so that differences in gene expression can analyzed between the two groups.
This study will further our basic knowledge of how aortic valve disease progresses in the early stages. This fundamental understanding may uncover new targets for earlier detection and therapeutic intervention, thereby reducing the impact of disease and improving health quality of life for millions of Canadians.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kwong, Andrea V
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~